Palatin Technologies Inc (PTN) stock
PTNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.15−0.21 (-3.92%)
Close on Nov 18, 2026Market cap $9.17MP/E –Yield –
Palatin Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Palatin Technologies's operating income for the twelve months ending Jun 30, 2026 was -$8.67M. For fiscal 2026 it was -$8.67M. The highest annual figure on record is $35.74M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$8.67M | – |
| FY2025 | Jun 30, 2025 | -$17.46M | – |
| FY2024 | Jun 30, 2024 | -$22.50M | – |
| FY2023 | Jun 30, 2023 | -$32.46M | – |
| FY2022 | Jun 30, 2022 | -$36.59M | – |
| FY2021 | Jun 30, 2021 | -$33.38M | – |
| FY2020 | Jun 30, 2020 | -$23.61M | -166.0% |
| FY2019 | Jun 30, 2019 | $35.74M | +37.9% |
| FY2018 | Jun 30, 2018 | $25.93M | 0.0% |
| FY2017 | Jun 30, 2017 | $25.93M | – |
| FY2016 | Jun 30, 2016 | -$49.25M | – |
| FY2015 | Jun 30, 2015 | -$17.29M | – |
| FY2014 | Jun 30, 2014 | -$15.79M | – |
| FY2013 | Jun 30, 2013 | -$15.59M | – |
| FY2012 | Jun 30, 2012 | -$18.79M | – |
| FY2011 | Jun 30, 2011 | -$13.65M | – |
| FY2010 | Jun 30, 2010 | -$3.01M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$4.42M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$1.58M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$7.33M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $4.66M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$2.27M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$4.81M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$2.61M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$7.76M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$8.34M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$10.82M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$7.30M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$13.10M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$7.82M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$8.45M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$7.22M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$13.70M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$6.49M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$9.25M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$3.95M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$7.39M | -114.2% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$5.71M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$5.64M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$4.86M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $52.19M | +325.3% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$5.76M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$5.05M | -271.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$5.63M | -150.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $12.27M | -75.9% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$517.44K | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $2.94M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $11.23M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $50.82M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$3.01M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$9.44M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$12.44M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$12.74M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$12.09M | – |
See a number that looks wrong?